New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
CASI Pharmaceuticals Inc. (CASIF) vs Dyadic International Inc. (DYAI)
- CASI Pharmaceuticals Inc. CASIF 0.11 +10.00%
- Dyadic International Inc. DYAI 0.29 −6.45%
CASI Pharmaceuticals Inc. and Dyadic International Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. and Dyadic International Inc. are of similar size ($12.5M and $12.4M). Dyadic International Inc. grew revenue faster over the last twelve months: −7.64% against −27.4%. Dyadic International Inc. has the higher net margin (−226.9% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Dyadic International Inc. leads on 8 and CASI Pharmaceuticals Inc. on 7.
Valuation
Profitability
| Metric | CASIF | DYAI | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.65% | 17.85% | 70.18% |
| Operating margin | (206.87%) | (237.12%) | 0.00% |
| Net margin | (232.03%) | (226.87%) | 0.00% |
| Free cash flow margin | — | (227.93%) | 0.00% |
| Return on equity | 271.28% | (47,316.89%) | (51.58%) |
| Return on assets | (121.17%) | (71.43%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack